Espay wins Lancet Neurology 20th anniversary essay competition

Essay conveys what future patient visit could look like

An essay on neurology written by Alberto Espay, MD, has won Lancet Neurologys 20th anniversary essay competition. The essay, “Your After-visit Summary: May 29, 2042” revolves around the diagnostic debriefing to a fictional patient of his new diagnosis of Parkinson’s disease, with biomedical analysis of test results informing a tailored treatment plan.

The essay is available online and will be printed in Lancet Neurology’s 20th anniversary edition in May.

Espay says he was thrilled to win the competition “because it meant that the vision of the essay, a picture vastly different than what we have been doing in caring for our patients, could gain currency with a global readership of neurologists.”

The essay was meant to convey what a future visit with a patient with Parkinson’s disease would look like. 

“Rather than saying, ‘You have Parkinson’s based on my experience; trust me,’ we will be saying, 'You have something we have called Parkinson’s, but have no idea what it means,’” Espay says. “We would engage in identifying the biological drivers of each person affected, recognizing that treatments to slow progression can only succeed if tailored to those most biologically suitable to benefit.”

Espay, the James J. and Joan A. Gardner Family Center for Parkinson’s Disease Research Endowed Chair in the Department of Neurology and Rehabilitation Medicine, says medicine is about a decade away from realizing the vision of his essay. He adds the essay was inspired by work currently in progress by the Cincinnati Cohort Biomarker Program, which is trying to unravel the individual biological abnormalities of those affected with neurodegenerative disorders. 

“Ultimately, the clinical diagnosis is but a human-made construct about which nature has no idea. And since nature can’t be fooled, we need to be agnostic to our labels and subtype individuals with neurodegenerative disorders according to their biology, not the classification we have used at the bedside for over a century,” he says.

Featured photo at top by Colleen Kelley/UC Creative + Brand 

Related Stories

1 Lowering blood pressure after clot removal may not be...

September 22, 2023 and HealthDay highlighted University of Cincinnati research recently published in JAMA that found using blood pressure medications to lower the top number of blood pressure readings (systolic blood pressure) may not be safe or effective among people who have an acute ischemic stroke and undergo a successful mechanical clot removal.


Know Stroke Podcast: UC expert discusses past, present and...

September 21, 2023

The University of Cincinnati's Joseph Broderick, MD, recently joined the Know Stroke Podcast to discuss the current state of stroke research, including the FASTEST trial he is leading to test a potential treatment for strokes caused by ruptured blood vessels in the brain.

Debug Query for this